QQQ   276.39 (+1.75%)
AAPL   115.32 (+3.71%)
MSFT   204.72 (+1.01%)
FB   280.83 (+4.92%)
GOOGL   1,556.88 (+3.05%)
AMZN   3,211.01 (+1.52%)
TSLA   410.83 (+1.18%)
NVDA   520.96 (+3.14%)
BABA   312.56 (+1.50%)
CGC   18.78 (+2.40%)
GE   7.37 (-0.67%)
MU   50.48 (+0.96%)
AMD   78.02 (+2.12%)
T   26.76 (+0.98%)
F   7.90 (+2.60%)
ACB   4.09 (+6.79%)
GILD   58.53 (-0.32%)
NFLX   504.21 (+3.70%)
NIO   31.99 (+16.28%)
BA   148.29 (+0.10%)
DIS   121.54 (+2.59%)
QQQ   276.39 (+1.75%)
AAPL   115.32 (+3.71%)
MSFT   204.72 (+1.01%)
FB   280.83 (+4.92%)
GOOGL   1,556.88 (+3.05%)
AMZN   3,211.01 (+1.52%)
TSLA   410.83 (+1.18%)
NVDA   520.96 (+3.14%)
BABA   312.56 (+1.50%)
CGC   18.78 (+2.40%)
GE   7.37 (-0.67%)
MU   50.48 (+0.96%)
AMD   78.02 (+2.12%)
T   26.76 (+0.98%)
F   7.90 (+2.60%)
ACB   4.09 (+6.79%)
GILD   58.53 (-0.32%)
NFLX   504.21 (+3.70%)
NIO   31.99 (+16.28%)
BA   148.29 (+0.10%)
DIS   121.54 (+2.59%)
QQQ   276.39 (+1.75%)
AAPL   115.32 (+3.71%)
MSFT   204.72 (+1.01%)
FB   280.83 (+4.92%)
GOOGL   1,556.88 (+3.05%)
AMZN   3,211.01 (+1.52%)
TSLA   410.83 (+1.18%)
NVDA   520.96 (+3.14%)
BABA   312.56 (+1.50%)
CGC   18.78 (+2.40%)
GE   7.37 (-0.67%)
MU   50.48 (+0.96%)
AMD   78.02 (+2.12%)
T   26.76 (+0.98%)
F   7.90 (+2.60%)
ACB   4.09 (+6.79%)
GILD   58.53 (-0.32%)
NFLX   504.21 (+3.70%)
NIO   31.99 (+16.28%)
BA   148.29 (+0.10%)
DIS   121.54 (+2.59%)
QQQ   276.39 (+1.75%)
AAPL   115.32 (+3.71%)
MSFT   204.72 (+1.01%)
FB   280.83 (+4.92%)
GOOGL   1,556.88 (+3.05%)
AMZN   3,211.01 (+1.52%)
TSLA   410.83 (+1.18%)
NVDA   520.96 (+3.14%)
BABA   312.56 (+1.50%)
CGC   18.78 (+2.40%)
GE   7.37 (-0.67%)
MU   50.48 (+0.96%)
AMD   78.02 (+2.12%)
T   26.76 (+0.98%)
F   7.90 (+2.60%)
ACB   4.09 (+6.79%)
GILD   58.53 (-0.32%)
NFLX   504.21 (+3.70%)
NIO   31.99 (+16.28%)
BA   148.29 (+0.10%)
DIS   121.54 (+2.59%)
Log in
NASDAQ:APVO

Aptevo Therapeutics SEC Filings & 10K Form

$6.59
+0.38 (+6.12 %)
(As of 10/29/2020 12:00 AM ET)
Add
Compare
Today's Range
$6.24
Now: $6.59
$6.76
50-Day Range
$6.21
MA: $7.36
$8.04
52-Week Range
$2.94
Now: $6.59
$11.73
Volume40,498 shs
Average Volume244,031 shs
Market Capitalization$21.31 million
P/E RatioN/A
Dividend YieldN/A
Beta2.5

SEC Filings

Aptevo Therapeutics (NASDAQ:APVO) SEC Filings

DateFilerForm TypeView
08/27/2020
3:51 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2020
3:38 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2020
8:40 PM
Aptevo Therapeutics (Issuer)
White Marvin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2020
8:39 PM
Aptevo Therapeutics (Issuer)
Niederhuber John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2020
8:37 PM
Aptevo Therapeutics (Issuer)
Maddux Randy Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2020
8:23 PM
Aptevo Therapeutics (Issuer)
Grant Grady III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2020
8:18 PM
Aptevo Therapeutics (Issuer)
Kunz Barbara Lopez (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2020
8:18 PM
Aptevo Therapeutics (Issuer)
El-Hibri Fuad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2020
8:11 PM
Abdun-Nabi Daniel (Reporting)
Aptevo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2020
3:02 PM
Aptevo Therapeutics (Subject)
Form SC TO-I
06/25/2020
8:28 AM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/13/2020
3:51 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2020
4:29 PM
Aptevo Therapeutics (Filer)
Form PRE 14A
03/25/2020
2:22 PM
Aptevo Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/19/2020
5:35 PM
Aptevo Therapeutics (Issuer)
White Marvin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2020
5:34 PM
Aptevo Therapeutics (Issuer)
Mitchell Shawnte (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2020
5:34 PM
Aptevo Therapeutics (Issuer)
Maddux Randy Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2020
5:34 PM
Aptevo Therapeutics (Issuer)
Lamothe Jeffrey G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2020
5:33 PM
Aptevo Therapeutics (Issuer)
Gross Jane A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2020
5:33 PM
Adelman Michael (Reporting)
Aptevo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2020
8:24 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2020
1:37 PM
Aptevo Therapeutics (Subject)
HIRSCHMAN ORIN (Filed by)
Form SC 13G
01/31/2020
4:21 PM
Aptevo Therapeutics (Filer)
Form PRE 14A
11/07/2019
11:53 AM
Aptevo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2019
11:39 AM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2019
7:56 PM
Aptevo Therapeutics (Issuer)
White Marvin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2019
7:55 PM
Aptevo Therapeutics (Issuer)
Mitchell Shawnte (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2019
7:54 PM
Aptevo Therapeutics (Issuer)
Maddux Randy Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2019
7:53 PM
Aptevo Therapeutics (Issuer)
Lamothe Jeffrey G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2019
7:52 PM
Aptevo Therapeutics (Issuer)
Gross Jane A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2019
7:50 PM
Adelman Michael (Reporting)
Aptevo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2019
3:32 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2019
5:35 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2019
3:31 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2019
3:48 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2019
7:29 AM
Aptevo Therapeutics (Issuer)
Maddux Randy Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2019
8:46 PM
Aptevo Therapeutics (Issuer)
El-Hibri Fuad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2019
7:02 AM
Aptevo Therapeutics (Filer)
Form 424B5
08/09/2019
11:26 AM
Aptevo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2019
11:19 AM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2019
5:49 PM
Aptevo Therapeutics (Issuer)
El-Hibri Fuad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2019
5:49 PM
Aptevo Therapeutics (Issuer)
El-Hibri Fuad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2019
3:19 PM
Aptevo Therapeutics (Issuer)
El-Hibri Fuad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2019
5:18 PM
Aptevo Therapeutics (Issuer)
El-Hibri Fuad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2019
4:12 PM
Aptevo Therapeutics (Issuer)
El-Hibri Fuad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2019
3:50 PM
Aptevo Therapeutics (Issuer)
El-Hibri Fuad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2019
4:54 PM
Aptevo Therapeutics (Issuer)
El-Hibri Fuad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2019
11:41 AM
Aptevo Therapeutics (Issuer)
El-Hibri Fuad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2019
3:10 PM
Aptevo Therapeutics (Issuer)
El-Hibri Fuad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
6:11 PM
Abdun-Nabi Daniel (Reporting)
Aptevo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
12:58 PM
Aptevo Therapeutics (Issuer)
White Marvin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
1:57 PM
Aptevo Therapeutics (Issuer)
Kunz Barbara Lopez (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
2:19 PM
Aptevo Therapeutics (Issuer)
Harsanyi Zsolt (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
2:18 PM
Aptevo Therapeutics (Issuer)
Maddux Randy Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2019
12:02 PM
Aptevo Therapeutics (Issuer)
El-Hibri Fuad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2019
12:01 PM
Aptevo Therapeutics (Issuer)
Harsanyi Zsolt (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2019
12:00 PM
Aptevo Therapeutics (Issuer)
Kunz Barbara Lopez (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2019
11:59 AM
Aptevo Therapeutics (Issuer)
Grant Grady III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2019
11:58 AM
Aptevo Therapeutics (Issuer)
Niederhuber John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2019
11:54 AM
Abdun-Nabi Daniel (Reporting)
Aptevo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2019
5:12 PM
Aptevo Therapeutics (Issuer)
Grant Grady III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2019
6:22 PM
Aptevo Therapeutics (Issuer)
White Marvin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2019
8:27 PM
Aptevo Therapeutics (Issuer)
White Marvin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2019
9:00 AM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2019
8:01 AM
Aptevo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/23/2019
5:03 AM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2019
4:14 PM
Aptevo Therapeutics (Filer)
Form DEFA14A
04/05/2019
4:12 PM
Aptevo Therapeutics (Filer)
Form DEF 14A
03/22/2019
3:16 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2019
4:20 PM
Aptevo Therapeutics (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
Form SC 13G
03/20/2019
2:58 PM
Aptevo Therapeutics (Subject)
HIRSCHMAN ORIN (Filed by)
Form SC 13G
03/18/2019
3:56 PM
Aptevo Therapeutics (Subject)
Stonepine Capital Management, LLC (Filed by)
Form SC 13G
03/18/2019
1:01 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2019
12:33 PM
Aptevo Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/12/2019
3:28 PM
Aptevo Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G
03/11/2019
8:21 AM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/08/2019
5:13 AM
Aptevo Therapeutics (Filer)
Form 424B5
03/06/2019
4:29 PM
Aptevo Therapeutics (Filer)
Form 424B5
03/04/2019
8:10 PM
Aptevo Therapeutics (Issuer)
White Marvin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
8:09 PM
Aptevo Therapeutics (Issuer)
Stromatt Scott C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
8:08 PM
Aptevo Therapeutics (Issuer)
Mitchell Shawnte (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
8:06 PM
Aptevo Therapeutics (Issuer)
Maddux Randy Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
8:05 PM
Aptevo Therapeutics (Issuer)
Lamothe Jeffrey G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
8:04 PM
Aptevo Therapeutics (Issuer)
Gross Jane A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
8:03 PM
Adelman Michael (Reporting)
Aptevo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2019
4:04 PM
Aptevo Therapeutics (Filer)
Form 424B5
02/12/2019
2:47 PM
Aptevo Therapeutics (Subject)
Sessa Capital , L.P. (0001618360) (Filed by)
Form SC 13G/A
02/12/2019
1:18 PM
Aptevo Therapeutics (Subject)
RENAISSANCE TECHNOLOGIES LLC (Filed by)
Form SC 13G
02/08/2019
6:52 AM
Aptevo Therapeutics (Subject)
DIMENSIONAL FUND ADVISORS LP (Filed by)
Form SC 13G/A
01/02/2019
4:15 PM
Aptevo Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
12/07/2018
5:28 PM
Aptevo Therapeutics (Issuer)
Maddux Randy Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2018
9:23 AM
Aptevo Therapeutics (Issuer)
White Marvin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2018
3:45 PM
Aptevo Therapeutics (Issuer)
Mitchell Shawnte (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2018
7:38 PM
Adelman Michael (Reporting)
Aptevo Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/10/2018
7:37 PM
Aptevo Therapeutics (Issuer)
Mitchell Shawnte (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/09/2018
1:37 PM
Aptevo Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/09/2018
12:56 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2018
8:06 AM
Aptevo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2018
4:19 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/27/2018
3:15 PM
Aptevo Therapeutics (Filer)
Form 10-K/A
This page was last updated on 10/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.